These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3552817)

  • 21. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans.
    Tillil H; Shapiro ET; Rubenstein AH; Galloway JA; Polonsky KS
    Diabetes; 1988 Oct; 37(10):1351-7. PubMed ID: 3046967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The limitations to and valid use of C-peptide as a marker of the secretion of insulin.
    Polonsky K; Frank B; Pugh W; Addis A; Karrison T; Meier P; Tager H; Rubenstein A
    Diabetes; 1986 Apr; 35(4):379-86. PubMed ID: 3514322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative evaluation of the effect of low-intensity exercise on insulin secretion in man.
    Levitt NS; Hirsch L; Rubenstein AH; Polonsky KS
    Metabolism; 1993 Jul; 42(7):829-33. PubMed ID: 8345793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
    Rudenski AS; Hosker JP; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1988 Jun; 37(6):526-34. PubMed ID: 3287091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of a dawn phenomenon in normal adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Horm Res; 1990; 34(1):27-32. PubMed ID: 1963621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
    Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
    Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aging on insulin secretion.
    Gumbiner B; Polonsky KS; Beltz WF; Wallace P; Brechtel G; Fink RI
    Diabetes; 1989 Dec; 38(12):1549-56. PubMed ID: 2684711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice.
    Ahrén B; Thomaseth K; Pacini G
    Diabetologia; 2005 Oct; 48(10):2140-6. PubMed ID: 16132949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics.
    Watanabe RM; Volund A; Roy S; Bergman RN
    J Clin Endocrinol Metab; 1989 Oct; 69(4):790-7. PubMed ID: 2674187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.
    Hovorka R; Koukkou E; Southerden D; Powrie JK; Young MA
    Diabetologia; 1998 May; 41(5):548-54. PubMed ID: 9628272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of high-dose biosynthetic human C-peptide on pancreatic hormone release in normal subjects.
    Wojcikowski C; Blackman J; Ostrega D; Lewis G; Galloway J; Rubenstein AH; Polonsky KS
    Metabolism; 1990 Aug; 39(8):827-32. PubMed ID: 2198434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics.
    Vølund A; Polonsky KS; Bergman RN
    Diabetes; 1987 Oct; 36(10):1195-202. PubMed ID: 2888696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.
    Tóth F; Frank N; Martin-Jiménez T; Elliott SB; Geor RJ; Boston RC
    Equine Vet J; 2010 Mar; 42(2):149-55. PubMed ID: 20156251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.
    Blackman JD; Polonsky KS; Jaspan JB; Sturis J; Van Cauter E; Thistlethwaite JR
    Diabetes; 1992 Oct; 41(10):1346-54. PubMed ID: 1397710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT.
    Tura A; Ludvik B; Nolan JJ; Pacini G; Thomaseth K
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E966-74. PubMed ID: 11595652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
    Jones CN; Pei D; Staris P; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1834-8. PubMed ID: 9177392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by proinsulin of endogenous C-peptide release in healthy man.
    Waldhäusl WK; Bratusch-Marrain P; Gasić S; Komjati M; Heding L
    Am J Physiol; 1986 Aug; 251(2 Pt 1):E139-45. PubMed ID: 3526918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of methods for measurement of insulin secretion in humans in vivo.
    Kjems LL; Christiansen E; Vølund A; Bergman RN; Madsbad S
    Diabetes; 2000 Apr; 49(4):580-8. PubMed ID: 10871195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the inhibitory effect of insulin and hypoglycemia on insulin secretion in humans.
    Fruehwald-Schultes B; Kern W; Born J; Fehm HL; Peters A
    Metabolism; 2000 Jul; 49(7):950-3. PubMed ID: 10910009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.